Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly Japanese.


Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 01 06 2019
accepted: 11 10 2019
pubmed: 24 10 2019
medline: 10 4 2020
entrez: 24 10 2019
Statut: ppublish

Résumé

Metabolic syndrome (MetS) is increasing worldwide with the continuous increase in obesity prevalence. Chronic kidney disease (CKD) is also a major public health problem, but there is controversy over whether baseline MetS is a predictor of decreased renal function among Japanese community-dwelling middle-aged and elderly Japanese. We conducted a prospective cohort study designed as part of the Nomura study. We recruited a random sample of 410 men aged 68 ± 8 (mean ± standard deviation; range, 50-95) years and 549 women aged 69 ± 7 (50-84) years during their annual health examination in a single community. We examined the relationship between baseline MetS and renal dysfunction after a 3-year evaluation based on estimated glomerular filtration rate (eGFR Of the 959 participants, 413 (43.1%) had MetS at baseline. Annual eGFR decline rate was significantly greater in those with MetS than in those without MetS, and the annual eGFR decline rate of < - 1.2 mL/min/1.73 m Low HDL-C and elevated HbA1c levels correlated significantly with eGFR decline in a short period of 3 years. MetS also showed a significant association with eGFR decline. This study suggests the importance of low HDL-C and elevated HbA1c in the effect of MetS on eGFR decline rather than obesity among Japanese community-dwelling middle-aged and elderly Japanese without CKD.

Identifiants

pubmed: 31642000
doi: 10.1007/s11255-019-02320-0
pii: 10.1007/s11255-019-02320-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2285-2294

Références

JAMA. 2004 Feb 18;291(7):844-50
pubmed: 14970063
BMC Public Health. 2019 Feb 14;19(1):192
pubmed: 30764803
Eur Heart J. 2007 Apr;28(7):857-64
pubmed: 17303589
J Hypertens. 1999 Apr;17(4):555-60
pubmed: 10404958
Curr Opin Nephrol Hypertens. 2013 Mar;22(2):198-203
pubmed: 23340215
Am J Kidney Dis. 2008 Jul;52(1):29-38
pubmed: 18511168
Kidney Int. 2017 May;91(5):1224-1235
pubmed: 28187985
Nephrology (Carlton). 2012 Aug;17(6):532-8
pubmed: 22487238
Kidney Int. 2005 Jun;67(6):2089-100
pubmed: 15882252
Kidney Int. 2015 Nov;88(5):950-7
pubmed: 26221752
J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32
pubmed: 20863953
J Clin Endocrinol Metab. 2003 Oct;88(10):4673-6
pubmed: 14557439
Kidney Int. 2007 Apr;71(7):693-700
pubmed: 17290290
Atherosclerosis. 2010 Aug;211(2):612-7
pubmed: 20362993
Kidney Int Suppl (2011). 2013 Jan;3(1):63-72
pubmed: 25018976
J Am Soc Nephrol. 2005 Jul;16(7):2134-40
pubmed: 15901764
Prim Care Diabetes. 2011 Jul;5(2):95-102
pubmed: 21474403
Diabetes Care. 2005 Sep;28(9):2289-304
pubmed: 16123508
J Am Soc Nephrol. 2005 Mar;16(3):763-73
pubmed: 15659562
Asia Pac J Clin Nutr. 2007;16(2):362-7
pubmed: 17468095
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):830-843
pubmed: 30641817
Eur J Epidemiol. 2010 Jun;25(6):375-84
pubmed: 20425137
Clin Exp Nephrol. 2009 Dec;13(6):621-30
pubmed: 19513802
PLoS One. 2014 May 07;9(5):e93795
pubmed: 24807226
Am J Clin Nutr. 2007 Dec;86(6):1642-8
pubmed: 18065581
Am J Kidney Dis. 2005 Nov;46(5):871-80
pubmed: 16253727
Circulation. 2005 Dec 13;112(24):3713-21
pubmed: 16344402
JPEN J Parenter Enteral Nutr. 2004 Nov-Dec;28(6):410-5
pubmed: 15568287
Biomed Res Int. 2016;2016:9241278
pubmed: 27200378
Metab Syndr Relat Disord. 2017 Oct;15(8):416-422
pubmed: 28832275
Clin Chim Acta. 2017 Jul;470:103-108
pubmed: 28501388
Hypertens Res. 2007 Oct;30(10):937-43
pubmed: 18049025
Clin J Am Soc Nephrol. 2011 Oct;6(10):2364-73
pubmed: 21852664
J Clin Neurosci. 2017 Jun;40:34-38
pubmed: 28268148
Diabetes Care. 2003 Nov;26(11):3153-9
pubmed: 14578254
Hypertens Res. 2000 Jul;23(4):303-10
pubmed: 10912765
BMC Public Health. 2016 Mar 03;16:220
pubmed: 26939609
BMC Nephrol. 2013 Jun 02;14:118
pubmed: 23725496
JAMA. 1999 Dec 8;282(22):2131-5
pubmed: 10591334

Auteurs

Ryuichi Kawamoto (R)

Department of Community Medicine, Ehime University Graduate School of Medicine, Shizugawa, Toon-city, Ehime, 791-0204, Japan. rykawamo@m.ehime-u.ac.jp.
Department of Internal Medicine, Seiyo Municipal Nomura Hospital, 9-53 Nnomura, Nomura-cho, Seiyo-city, Ehime, 797-1212, Japan. rykawamo@m.ehime-u.ac.jp.

Taichi Akase (T)

Department of Community Medicine, Ehime University Graduate School of Medicine, Shizugawa, Toon-city, Ehime, 791-0204, Japan.
Department of Internal Medicine, Seiyo Municipal Nomura Hospital, 9-53 Nnomura, Nomura-cho, Seiyo-city, Ehime, 797-1212, Japan.

Daisuke Ninomiya (D)

Department of Community Medicine, Ehime University Graduate School of Medicine, Shizugawa, Toon-city, Ehime, 791-0204, Japan.
Department of Internal Medicine, Seiyo Municipal Nomura Hospital, 9-53 Nnomura, Nomura-cho, Seiyo-city, Ehime, 797-1212, Japan.

Teru Kumagi (T)

Department of Community Medicine, Ehime University Graduate School of Medicine, Shizugawa, Toon-city, Ehime, 791-0204, Japan.

Asuka Kikuchi (A)

Department of Community Medicine, Ehime University Graduate School of Medicine, Shizugawa, Toon-city, Ehime, 791-0204, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH